Function  ||| S:0 E:9 ||| NN
of  ||| S:9 E:12 ||| IN
the  ||| S:12 E:16 ||| DT
airway  ||| S:16 E:23 ||| JJ
epithelium  ||| S:23 E:34 ||| NN
in  ||| S:34 E:37 ||| IN
asthma  ||| S:37 E:44 ||| JJ
Asthma  ||| S:44 E:51 ||| NNP
is  ||| S:51 E:54 ||| VBZ
traditionally  ||| S:54 E:68 ||| RB
defined  ||| S:68 E:76 ||| VBN
as  ||| S:76 E:79 ||| IN
a  ||| S:79 E:81 ||| DT
chronic  ||| S:81 E:89 ||| JJ
disease  ||| S:89 E:97 ||| NN
characterized  ||| S:97 E:111 ||| VBN
by  ||| S:111 E:114 ||| IN
bronchial  ||| S:114 E:124 ||| JJ
hyper-responsiveness  ||| S:124 E:145 ||| JJ
and  ||| S:145 E:149 ||| CC
lung  ||| S:149 E:154 ||| NN
inflammation ||| S:154 E:166 ||| NN
.  ||| S:166 E:168 ||| .
The  ||| S:168 E:172 ||| DT
airway  ||| S:172 E:179 ||| JJ
inflammation  ||| S:179 E:192 ||| NN
and  ||| S:192 E:196 ||| CC
remodelling  ||| S:196 E:208 ||| VBP
together  ||| S:208 E:217 ||| RB
likely  ||| S:217 E:224 ||| RB
explain  ||| S:224 E:232 ||| VB
the  ||| S:232 E:236 ||| DT
clinical  ||| S:236 E:245 ||| JJ
manifestations  ||| S:245 E:260 ||| NNS
of  ||| S:260 E:263 ||| IN
asthma ||| S:263 E:269 ||| NN
.  ||| S:269 E:271 ||| .
The  ||| S:271 E:275 ||| DT
mechanisms  ||| S:275 E:286 ||| NNS
by  ||| S:286 E:289 ||| IN
which  ||| S:289 E:295 ||| WDT
the  ||| S:295 E:299 ||| DT
external  ||| S:299 E:308 ||| JJ
environmental  ||| S:308 E:322 ||| JJ
cues ||| S:322 E:326 ||| NNS
,  ||| S:326 E:328 ||| ,
together  ||| S:328 E:337 ||| RB
with  ||| S:337 E:342 ||| IN
the  ||| S:342 E:346 ||| DT
complex  ||| S:346 E:354 ||| JJ
genetic  ||| S:354 E:362 ||| JJ
actions ||| S:362 E:369 ||| NNS
,  ||| S:369 E:371 ||| ,
propagate  ||| S:371 E:381 ||| VBG
the  ||| S:381 E:385 ||| DT
inflammatory  ||| S:385 E:398 ||| JJ
process  ||| S:398 E:406 ||| NN
that  ||| S:406 E:411 ||| IN
characterizes  ||| S:411 E:425 ||| JJ
asthma  ||| S:425 E:432 ||| NNS
are  ||| S:432 E:436 ||| VBP
beginning  ||| S:436 E:446 ||| VBG
to  ||| S:446 E:449 ||| TO
be  ||| S:449 E:452 ||| VB
understood ||| S:452 E:462 ||| VBN
.  ||| S:462 E:464 ||| .
There  ||| S:464 E:470 ||| EX
is  ||| S:470 E:473 ||| VBZ
also  ||| S:473 E:478 ||| RB
an  ||| S:478 E:481 ||| DT
evolving  ||| S:481 E:490 ||| JJ
awareness  ||| S:490 E:500 ||| NN
of  ||| S:500 E:503 ||| IN
the  ||| S:503 E:507 ||| DT
active  ||| S:507 E:514 ||| JJ
participation  ||| S:514 E:528 ||| NN
of  ||| S:528 E:531 ||| IN
structural  ||| S:531 E:542 ||| JJ
elements ||| S:542 E:550 ||| NNS
,  ||| S:550 E:552 ||| ,
such  ||| S:552 E:557 ||| JJ
as  ||| S:557 E:560 ||| IN
the  ||| S:560 E:564 ||| DT
airway  ||| S:564 E:571 ||| JJ
epithelium ||| S:571 E:581 ||| NN
,  ||| S:581 E:583 ||| ,
airway  ||| S:583 E:590 ||| JJ
smooth  ||| S:590 E:597 ||| JJ
muscle ||| S:597 E:603 ||| NN
,  ||| S:603 E:605 ||| ,
and  ||| S:605 E:609 ||| CC
endothelium ||| S:609 E:620 ||| NN
,  ||| S:620 E:622 ||| ,
in  ||| S:622 E:625 ||| IN
this  ||| S:625 E:630 ||| DT
process ||| S:630 E:637 ||| NN
;  ||| S:637 E:639 ||| :
these  ||| S:639 E:645 ||| DT
structural  ||| S:645 E:656 ||| JJ
elements  ||| S:656 E:665 ||| NNS
within  ||| S:665 E:672 ||| IN
the  ||| S:672 E:676 ||| DT
lung  ||| S:676 E:681 ||| NN
and  ||| S:681 E:685 ||| CC
the  ||| S:685 E:689 ||| DT
bone  ||| S:689 E:694 ||| NN
marrow  ||| S:694 E:701 ||| NNS
serve  ||| S:701 E:707 ||| VBP
as  ||| S:707 E:710 ||| RB
reservoirs  ||| S:710 E:721 ||| VBN
for  ||| S:721 E:725 ||| IN
and  ||| S:725 E:729 ||| CC
the  ||| S:729 E:733 ||| DT
source  ||| S:733 E:740 ||| NN
of  ||| S:740 E:743 ||| IN
inflammatory  ||| S:743 E:756 ||| JJ
cells  ||| S:756 E:762 ||| NNS
and  ||| S:762 E:766 ||| CC
their  ||| S:766 E:772 ||| PRP$
precursors ||| S:772 E:782 ||| NN
.  ||| S:782 E:784 ||| .
Although  ||| S:784 E:793 ||| IN
often  ||| S:793 E:799 ||| RB
viewed  ||| S:799 E:806 ||| VBN
as  ||| S:806 E:809 ||| IN
separate  ||| S:809 E:818 ||| JJ
mechanistic  ||| S:818 E:830 ||| JJ
entities ||| S:830 E:838 ||| NNS
,  ||| S:838 E:840 ||| ,
so-called  ||| S:840 E:850 ||| JJ
innate  ||| S:850 E:857 ||| NN
and  ||| S:857 E:861 ||| CC
acquired  ||| S:861 E:870 ||| VBD
immunity  ||| S:870 E:879 ||| VBN
often  ||| S:879 E:885 ||| RB
overlap  ||| S:885 E:893 ||| VB
in  ||| S:893 E:896 ||| IN
the  ||| S:896 E:900 ||| DT
propagation  ||| S:900 E:912 ||| NN
of  ||| S:912 E:915 ||| IN
the  ||| S:915 E:919 ||| DT
asthmatic  ||| S:919 E:929 ||| JJ
response ||| S:929 E:937 ||| NN
.  ||| S:937 E:939 ||| .
This  ||| S:939 E:944 ||| DT
review  ||| S:944 E:951 ||| NN
examines  ||| S:951 E:960 ||| VBZ
the  ||| S:960 E:964 ||| DT
newer  ||| S:964 E:970 ||| JJR
information  ||| S:970 E:982 ||| NN
on  ||| S:982 E:985 ||| IN
the  ||| S:985 E:989 ||| DT
pathophysiologic  ||| S:989 E:1006 ||| JJ
characteristics  ||| S:1006 E:1022 ||| NNS
of  ||| S:1022 E:1025 ||| IN
asthma  ||| S:1025 E:1032 ||| NN
and  ||| S:1032 E:1036 ||| CC
focuses  ||| S:1036 E:1044 ||| VBZ
on  ||| S:1044 E:1047 ||| IN
the  ||| S:1047 E:1051 ||| DT
role  ||| S:1051 E:1056 ||| NN
of  ||| S:1056 E:1059 ||| IN
airway  ||| S:1059 E:1066 ||| JJ
epithelium  ||| S:1066 E:1077 ||| NN
in  ||| S:1077 E:1080 ||| IN
the  ||| S:1080 E:1084 ||| DT
exacerbation  ||| S:1084 E:1097 ||| NN
of  ||| S:1097 E:1100 ||| IN
the  ||| S:1100 E:1104 ||| DT
disease ||| S:1104 E:1111 ||| NN
.  ||| S:1111 E:1113 ||| .
